Cargando…

Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors

Detalles Bibliográficos
Autores principales: Perez Horta, Zulmarie, Gillies, Stephen, Boyden, Margaret, Hank, Jaquelyn, Rahkmilevich, Alexander, Sondel, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288413/
http://dx.doi.org/10.1186/2051-1426-2-S3-P118
_version_ 1782351967491719168
author Perez Horta, Zulmarie
Gillies, Stephen
Boyden, Margaret
Hank, Jaquelyn
Rahkmilevich, Alexander
Sondel, Paul
author_facet Perez Horta, Zulmarie
Gillies, Stephen
Boyden, Margaret
Hank, Jaquelyn
Rahkmilevich, Alexander
Sondel, Paul
author_sort Perez Horta, Zulmarie
collection PubMed
description
format Online
Article
Text
id pubmed-4288413
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42884132015-01-15 Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors Perez Horta, Zulmarie Gillies, Stephen Boyden, Margaret Hank, Jaquelyn Rahkmilevich, Alexander Sondel, Paul J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288413/ http://dx.doi.org/10.1186/2051-1426-2-S3-P118 Text en Copyright © 2014 Horta et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Perez Horta, Zulmarie
Gillies, Stephen
Boyden, Margaret
Hank, Jaquelyn
Rahkmilevich, Alexander
Sondel, Paul
Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors
title Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors
title_full Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors
title_fullStr Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors
title_full_unstemmed Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors
title_short Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors
title_sort evaluation of novel immunocytokines that preferentially target high or intermediate affinity il-2 receptors
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288413/
http://dx.doi.org/10.1186/2051-1426-2-S3-P118
work_keys_str_mv AT perezhortazulmarie evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors
AT gilliesstephen evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors
AT boydenmargaret evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors
AT hankjaquelyn evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors
AT rahkmilevichalexander evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors
AT sondelpaul evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors